A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases

Yasuhiro Fujiwara, Yoshio Naomoto, Shunsuke Tanabe, Kazufumi Sakurama, Kazuhiro Noma, Toshio Nishikawa, Takayuki Motoki, Munenori Takaoka, Yasuhiro Shirakawa, Tomoki Yamatsuji, Junji Matsuoka, Noriaki Tanaka

Research output: Contribution to journalArticlepeer-review

Abstract

We report a case of a woman in her sixties having primary duodenal carcinoma with multiple liver metastases who was treated with oxaliplatin in combination with infusional 5-fluorouracil/Leucovorin (FOLFOX regimen). After completing 2 courses of the chemotherapy, computed tomography showed a partial response without any severe adverse events. Now at 8 months, the PR stage has been maintained. So far, no standard therapeutic strategy for metastatic duodenal carcinoma has been developed. However, we suggest a FOLFOX regimen can be highly effective as a safe approach for continuously maintaining the quality of life of patients with this rare type of cancer.

Original languageEnglish
Pages (from-to)655-657
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume36
Issue number4
Publication statusPublished - Apr 2009

Keywords

  • FOLFOX
  • Liver metastasis
  • Primary duodenal carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases'. Together they form a unique fingerprint.

Cite this